Cargando…

Time to market for drugs approved in Canada between 2014 and 2018: an observational study

OBJECTIVES: This study examines the length of time between when a patent application is filed in Canada for a new drug and when it is available for patients (time to market) and various components of that time. It also looks at whether various factors explain the time between patent application to N...

Descripción completa

Detalles Bibliográficos
Autor principal: Lexchin, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258566/
https://www.ncbi.nlm.nih.gov/pubmed/34226224
http://dx.doi.org/10.1136/bmjopen-2020-047557